Search

Your search keyword '"Marija, Vavlukis"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Marija, Vavlukis" Remove constraint Author: "Marija, Vavlukis"
125 results on '"Marija, Vavlukis"'

Search Results

2. Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease

6. Age and Gender Impact on Heart Rate Variability towards Noninvasive Glucose Measurement

7. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

8. Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development

10. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

11. Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease

12. Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

13. Adding ezetimibe to statin therapy: latest evidence and clinical implications

14. Sex differences and disparities in cardiovascular outcomes of COVID-19

15. Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low-to-moderate cardiovascular risk

16. Incremental Value of Cardiac Biomarkers in Mid-term Prognosis of Patients with Acute Coronary Syndrome

18. Acute Coronary Syndrome: The Risk to Young Women

19. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19

21. Left Ventricular Aneurysm with Recurrent Ventricular Tachycardia

22. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

23. Comparison of 24 h ECG Holter Monitoring with Real-time Long-term ECG Monitoring System using ECGalert Software and Savvy Single-Lead Patch

24. International Impact of COVID-19 on the Diagnosis of Heart Disease

26. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI

27. Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects

29. Diffuse Arterial Thrombosis as a First Manifestation of Occult Malignancy

30. Abstract 13310: Early Percutaneous Coronary Intervention: Risks and Outcomes in Patients With Cancer

31. Developing A Deep Learning Solution to Estimate Instantaneous Glucose Level from Heart Rate Variability

32. Distribution Analysis of Long-Term Heart Rate Variability Versus Blood Glucose

33. Cardiovascular disease and COVID-19:a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)

34. Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

35. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation

36. Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction

37. Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

38. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

39. Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

40. Heart Rate Variability of 30-minute ECG Measurements and Correlation to Glucose Levels

41. Abstract 13648: Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease

42. Added Value of Modified Anderson–Wilkins Acuteness Score in Prognostication of Patients with Acute Myocardial Infarction

43. Novel Inflammatory Biomarkers as Additional Value to Traditional Risk-factors in Cardiovascular Risk Stratification

44. Risk factors, revascularization therapies and cardiovascular mortality in countries with middle and low public health expenditure

45. Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease

46. Myocardial Infarction in Systemic Lupus Erythematosus - the Sex-Specific Risk Profile

47. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'

48. Myocardial Perfusion Abnormalities in Young and Premenopausal Women with Systemic Lupus Erythematosus, Detected with 99MTC MIBI Myocardial Perfusion Scintigraphy – Prevalence and Correlation with Proatherogenic Factors

49. Adding ezetimibe to statin therapy: latest evidence and clinical implications

50. Perfusión tejido-músculo evaluada mediante protocolo de un día de gammagrafía reposo-dipiramidol con 99m Tc-MIBI en pacientes no diabéticos y diabéticos

Catalog

Books, media, physical & digital resources